Equity Research, Broker Reports, and media content on Cosmo Pharmaceuticals NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Cosmo Pharmaceuticals NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Cosmo Pharmaceuticals NV

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Cosmo Pharmaceuticals NV. We currently have 16 research reports from 1 professional analysts.

Date Source Announcement
28Jun22 06:00 DGAP-AHD Cosmo announces acceptance of NDA submission of Cortiment® MMX® in Japan
28Jun22 06:00 DGAP-AHD Cosmo gibt Annahme des NDA-Antrags für Cortiment® MMX® in Japan bekannt
27May22 15:15 EQS-News Aktionärinnen und Aktionäre von Cosmo stimmen allen Tagungsordnungspunkten an der Generalversammlung zu
27May22 15:15 DGAP-News Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA
03May22 06:00 EQS-News COSMO VERKÜNDET ERWEITERUNG DER VEREINBARUNG MIT MEDTRONIC FÜR ELEVIEW(R) AUF ALLE LÄNDER AUSSER KANADA
03May22 06:00 DGAP-News COSMO ANNOUNCES EXPANDING THE AGREEMENT WITH MEDTRONIC FOR ELEVIEW(R) TO ALL COUNTRIES EXCEPT CANADA
23Mar22 06:00 DGAP-AHD COSMO ANNOUNCES FULL-YEAR RESULTS 2021; CONFIRMS BEATING GUIDANCE
  • Frequency of research reports

     

  • Research reports on

    Cosmo Pharmaceuticals NV

  • Providers covering

    Cosmo Pharmaceuticals NV